Digital · Origine US / UK

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Source: Marina Temkin · Publié 23 sept. 2026, 21:31

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Dans Digital, Marina Temkin place cette histoire au centre de la journée : The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s. FlexChar la retient parce qu’elle concentre recherches et discussion.

Brief éditorial FlexChar. L’article complet appartient à la source.

Lire la source originale

Blog

Confidentialité numérique : 9 changements qui comptent vraiment Outils numériques gratuits qui valent encore en 2026 Organiser sa semaine sans une énième app de productivité Windows lent : comment le réparer en 2026

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

À lire aussi

U.S. Intervention in the UN Security Council Meeting on "Artificial Intelligence and International Security"

Artificial Intelligence Will Not Make Us Extinct

If Amazon doesn’t know how to eliminate carbon emissions, then who does?

US diplomats told to use term ‘super intelligence’ not ‘artificial intelligence’ after Trump's call